Enrolling by invitationNCT03972345

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

Studying Placental insufficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Novo Nordisk A/S
Principal Investigator
Clinical Transparency (dept. 2834)
Novo Nordisk A/S
Intervention
Norditropin® FlexPro®(drug)
Enrollment
750 target
Eligibility
0-15 years · All sexes
Timeline
2019 – 2031

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03972345 on ClinicalTrials.gov

Other trials for Placental insufficiency

Additional recruiting or active studies for the same condition.

See all trials for Placental insufficiency →

← Back to all trials